BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 38043776)

  • 21. Aptamer-Targeted Attenuation of IL-2 Signaling in CD8
    Rajagopalan A; Berezhnoy A; Schrand B; Puplampu-Dove Y; Gilboa E
    Mol Ther; 2017 Jan; 25(1):54-61. PubMed ID: 28129128
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cordycepin-enriched Cordyceps militaris induces immunomodulation and tumor growth delay in mouse-derived breast cancer.
    Jeong MH; Lee CM; Lee SW; Seo SY; Seo MJ; Kang BW; Jeong YK; Choi YJ; Yang KM; Jo WS
    Oncol Rep; 2013 Oct; 30(4):1996-2002. PubMed ID: 23921598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effects of excreted/secreted antigens of Toxoplasma gondii on CD4+ CD25+ Foxp3+ T cells and NK cells of melanoma-bearing mice].
    Jiao YM; Zhang L; Ge YY; Liang YJ; Yong W
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2011 Jun; 23(3):301-6. PubMed ID: 22164498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exploiting a natural conformational switch to engineer an interleukin-2 'superkine'.
    Levin AM; Bates DL; Ring AM; Krieg C; Lin JT; Su L; Moraga I; Raeber ME; Bowman GR; Novick P; Pande VS; Fathman CG; Boyman O; Garcia KC
    Nature; 2012 Mar; 484(7395):529-33. PubMed ID: 22446627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective depletion of Foxp3+ regulatory T cells improves effective therapeutic vaccination against established melanoma.
    Klages K; Mayer CT; Lahl K; Loddenkemper C; Teng MW; Ngiow SF; Smyth MJ; Hamann A; Huehn J; Sparwasser T
    Cancer Res; 2010 Oct; 70(20):7788-99. PubMed ID: 20924102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IL-2 induces in vivo suppression by CD4(+)CD25(+)Foxp3(+) regulatory T cells.
    Brandenburg S; Takahashi T; de la Rosa M; Janke M; Karsten G; Muzzulini T; Orinska Z; Bulfone-Paus S; Scheffold A
    Eur J Immunol; 2008 Jun; 38(6):1643-53. PubMed ID: 18493984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Neuropilin-1 Antagonist Exerts Antitumor Immunity by Inhibiting the Suppressive Function of Intratumoral Regulatory T Cells.
    Jung K; Kim JA; Kim YJ; Lee HW; Kim CH; Haam S; Kim YS
    Cancer Immunol Res; 2020 Jan; 8(1):46-56. PubMed ID: 31554638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.
    Wang DW; Zhou RB; Yao YM; Zhu XM; Yin YM; Zhao GJ; Dong N; Sheng ZY
    J Pharmacol Exp Ther; 2010 Dec; 335(3):553-61. PubMed ID: 20843956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Interleukin-12 restores and promotes the T-cell immune function inhibited by 5-fluorouracil].
    Chi PD; Li L; Fan YY; Wu CY
    Ai Zheng; 2007 Aug; 26(8):801-8. PubMed ID: 17697537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of anti-CD25 monoclonal antibody on dendritic cell-tumor fusion vaccine efficacy in a murine melanoma model.
    Tan C; Reddy V; Dannull J; Ding E; Nair SK; Tyler DS; Pruitt SK; Lee WT
    J Transl Med; 2013 Jun; 11():148. PubMed ID: 23768240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Absence of amplification of CD4+CD25(high) regulatory T cells during in vitro expansion of tumor-infiltrating lymphocytes in melanoma patients.
    Knol AC; Lemaître F; Pandolfino MC; Volteau C; Quéreux G; Saiagh S; Khammari A; Viguier M; Dréno B
    Exp Dermatol; 2008 May; 17(5):436-45. PubMed ID: 18312383
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Administration of a CD25-directed immunotoxin, LMB-2, to patients with metastatic melanoma induces a selective partial reduction in regulatory T cells in vivo.
    Powell DJ; Felipe-Silva A; Merino MJ; Ahmadzadeh M; Allen T; Levy C; White DE; Mavroukakis S; Kreitman RJ; Rosenberg SA; Pastan I
    J Immunol; 2007 Oct; 179(7):4919-28. PubMed ID: 17878392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of the administration of high-dose interleukin-2 on immunoregulatory cell subsets in patients with advanced melanoma and renal cell cancer.
    van der Vliet HJ; Koon HB; Yue SC; Uzunparmak B; Seery V; Gavin MA; Rudensky AY; Atkins MB; Balk SP; Exley MA
    Clin Cancer Res; 2007 Apr; 13(7):2100-8. PubMed ID: 17404092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The immunoregulatory role of CD4⁺ FoxP3⁺ CD25⁻ regulatory T cells in lungs of mice infected with Bordetella pertussis.
    Coleman MM; Finlay CM; Moran B; Keane J; Dunne PJ; Mills KH
    FEMS Immunol Med Microbiol; 2012 Apr; 64(3):413-24. PubMed ID: 22211712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Costimulatory strength influences the differential effects of transforming growth factor beta1 for the generation of CD8+ regulatory T cells.
    Fan TM; Kranz DM; Flavell RA; Roy EJ
    Mol Immunol; 2008 May; 45(10):2937-50. PubMed ID: 18321576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Depletion of CD4+ CD25+ regulatory T cells promotes CCL21-mediated antitumor immunity.
    Zhou S; Chen L; Qin J; Li R; Tao H; Zhen Z; Chen H; Chen G; Yang Y; Liu B; She Z; Zhong C; Liang C
    PLoS One; 2013; 8(9):e73952. PubMed ID: 24023916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Partial reduction of human FOXP3+ CD4 T cells in vivo after CD25-directed recombinant immunotoxin administration.
    Powell DJ; Attia P; Ghetie V; Schindler J; Vitetta ES; Rosenberg SA
    J Immunother; 2008; 31(2):189-98. PubMed ID: 18481388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Depletion of CD4+CD25+ regulatory T cells enhances interleukin-2-induced antitumor immunity in a mouse model of colon adenocarcinoma.
    Imai H; Saio M; Nonaka K; Suwa T; Umemura N; Ouyang GF; Nakagawa J; Tomita H; Osada S; Sugiyama Y; Adachi Y; Takami T
    Cancer Sci; 2007 Mar; 98(3):416-23. PubMed ID: 17270031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of rapamycin and interleukin-2 on regulatory CD4+CD25+Foxp3+ T cells in mice after allogenic corneal transplantation.
    Wang X; Wang W; Xu J; Le Q
    Transplant Proc; 2013 Mar; 45(2):528-37. PubMed ID: 23267787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of FOXP3/NFAT Interaction Enhances T Cell Function after TCR Stimulation.
    Lozano T; Villanueva L; Durántez M; Gorraiz M; Ruiz M; Belsúe V; Riezu-Boj JI; Hervás-Stubbs S; Oyarzábal J; Bandukwala H; Lourenço AR; Coffer PJ; Sarobe P; Prieto J; Casares N; Lasarte JJ
    J Immunol; 2015 Oct; 195(7):3180-9. PubMed ID: 26324768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.